Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis
Authors:
- Yi-Shan LiuYLYi-Shan Liu
- Eng-Yen HuangEHEng-Yen Huang
- Shun-Chen HuangSHShun-Chen Huang
- Hsueh-Wen ChangHCHsueh-Wen Chang
- Chih-Weng TsengCTChih-Weng Tseng
- Chan-Chao ChangChienCCChan-Chao ChangChien
- 1 March 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (3) , 591-595
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patientsGynecologic Oncology, 2005
- The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based StudyGynecologic Oncology, 2000
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- Tumor Antigens CA 19.9, CA 125, and CEA in Carcinoma of the Uterine CervixGynecologic Oncology, 1995
- Serum CA125 regression in epithelial ovarian cancer: Correlation with reassessment findings and survivalGynecologic Oncology, 1992
- Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinomaGynecologic Oncology, 1990
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1990
- Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervixGynecologic Oncology, 1990
- Prognostic factors associated with radical hysterectomy failureGynecologic Oncology, 1987
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983